Some of the genes have been previously associated with cancer progression (T complex protein-1 beta [71], tetratricopeptide repeat protein-4 [72]), cancer survival (Bax inhibitor 1 [73], mitofusion 2 [74,75]), heterogeneous nuclear riboprotein A1 [76]), drug resistance (T complex protein-1, HSP70 [77]), or cancer cell migration (Hs1 binding protein [78,79]). This evidence concerns the gene TMBIM6 and cancer.